| 摘要 |
<p>Human AXOR29 polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Human AXOR29 is identified as a selective receptor for sphingosine-1-phosphate ('S-1-P') and di-hydro sphingosine-1-phosphate ('di-hydro S-1-P'). Also disclosed are methods for discovering agonists and antagonists of the interaction between S-1-P and di-hydro S-1-P and their cellular receptor, human AXOR29, which may have utility in the treatment of several human diseases and disorders, including, but not limited to the treatment of infections such as bacterial, fungal, protozoan and viral infections, particularly infections caused by HIV-1 or HIV-2; pain; cancers; diabetes, obesity; anorexia; bulimia; asthma; Parkinson's disease; acute heart failure; hypotension; hypertension; urinary retention; osteoporosis; angina pectoris; myocardial infarction; stroke; ulcers; asthma; allergie; benign prostatic hypertrophy; migraine; vomiting; psychotic and neurological disorders, including anxiety, schizophrenia, manic depression, depression, delirium, dementia, and severe mental retardation.</p> |
